To Upload your aptamers in our database
For LOGIN
# | Aptamer Name | Aptamer Target (General) | Aptamer Target (Specific) | Length | Affinity | Buffer | GC Content | Sequence | Reference |
---|---|---|---|---|---|---|---|---|---|
231 | Bfl-1 Anti-Apoptotic Protein (Apt27) | Protein | Bfl-1 Anti-Apoptotic Ptrotein | 13 | N/A nM | N/A | 5'-AIARLLAAILRIV-3' | Brien et al. "Characterization of Aptamers Targeting Bfl-1 Anti-Apoptotic Protein." Biochemistry, 50, (2011): 5120-5129. | |
232 | Bfl-1 Anti-Apoptotoc Protein (Apt50) | Protein | Bfl-1 Antio-Apoptotic Protein | 13 | N/A nM | N/A | 5'-MISLCNALQKVIN-3' | Brien et al. "Characterization of Aptamers Targeting Bfl-1 Anti-Apoptotic Protein." Biochemistry, 50, (2011): 5120-5129. | |
233 | Thrombopoietin Receptor (AF12505) | Protein | Thrombopoietin Receptor | 14 | 2 nM | N/A | NH2-IEGPTLRQWLAARA-COOCOOH | Cwirla et al. "Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural Cytokine." Science, 276(1997): 1696-1699. | |
234 | VEGF-stimulated HUVECs | Tissue | VEGF-stimulated human umbilical vein endothelial cells (HUVECs) | 15 | N/A nM | In vivo mice. | NH2-ASSSYPLIHWRPWAR-COOCOOH | Asai et al. "Suppression of tumor growth by novel peptides homing to tumor-derived new blood vessels." FEBS Letters, 510(2002): 206-210. | |
235 | PC-3 (G1) | Tissue | PC-3 Human Prostate Carcinoma | 15 | N/A nM | In vivo in mice. Washed with PBS. | NH2-IAGLATPGWSHWLAL-COOCOOH | Newton et al. "In Vivo Selection of Phage for the Optical Imaging of PC-3 Human Prostate Carcinoma in Mice." | |
236 | Protective Antigen (PA) of Bacilus anthracis (MMS_105) | Cells | Protective Antigen (PA) of Bacilus anthracis | 15 | 19.1 nM | Binding Buffer: PBSB (PBS buffer plus 0.5% BSA), 4°C | NH2-NWLCFTCGMDFIDPD-COOCOOH | Kogot et al. "Screening of Peptide Libraries against Protective Antigen of Bacillus anthracis in a Disposable Microfluidic Cartridge." PloS One, 6(11): e26925. doi:10.1371/journal.pone.0026925 | |
237 | VEGF-Stimulated HUVECs (ID# 354) | Protein | VEGF-Stimulated human umbilical vein endothelial cells (HUVECs) | 15 | N/A nM | In vivo mice. | 5'-DRWRPALPVVLFPLH-3' | Asai et al. "Isolation of a Novel Peptide Homing to Tumor-Derived Neovasculature That Suppresses Tumor Growth." Biological Pharmaceutical Bulletin, 25(2002): 904-906. | |
238 | Tenascin-C (peptide #1) | Protein | Tenascin C (TNC) | 15 | 4.58 µM | 0.1 M NaCO3, pH 8.6 | 5'-FHKHKSPALSPVGGG-3' | M Y Kim et al. Selection and Characterization of Tenascin C Targeting Peptide. Mol. Cells 33(2012): 71-77. | |
239 | Penetratin | Cells | Cell-penetrating peptide (CPP) | 16 | N/A nM | N/A | 5'-RQIKIWFQNRRMKWKK-3' | Derossi D, Joliot A, Chassaing G, and Prochiantz A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269: 10444-10450. | |
240 | VEGF receptor KDR and Flt-1 (v107) | Cells | VEGF receptor KDR and Flt-1 | 19 | 0.6 µM | Binding Buffer (0.5% (v/v) Tween20, 0.5% BSA in PBS) | NH2-GGNECDAIRMWEWECFERL-COOCOOH | Pan et al. "Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor." J Mol Biol, 316(2002): 769-787. |